Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability

Journal of the American College of Cardiology

Volumn 27, Issue 6, 1996, Pages 1422-1428

  Picano, Eugenio ^a   Ostojic, Miodrag ^b   Varga, Albert ^a,c   Sicari, Rosa ^a   Djordjevic Dikic, Ana ^b   Nedeljkovic, Ivana ^b   Torres, Marco ^a,d  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b Univ Inst for Cardiovasc Diseases

^c UNIVERSITY OF SZEGED   (Hungary)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE INJURY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION;

EID: 0029930465     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00621-4     Document Type: Article

References (39)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
2. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for "hibernating myocardium." J Am Coll Cardiol 1986;56: 978-85.
3. Rahimtoola SH. A perspective on the three large multivessel randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72 Suppl V:V-123-35.
4. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
5. Gould KL. Myocardial viability. What does it mean and how do we measure it? Circulation 1991;83:333-5.
6. Ross J Jr. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. Circulation 1991;83:1076-83.
7. Thomas JD, Topol E. Wanted: dead or alive. Assessment of myocardial viability after thrombolysis. Circulation 1993;88:797-9.
8. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15: 1021-31.
9. Barilla F, Gheorghiade KP, Alam M, Khaja F, Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-31.
10. Cigarroa CG, De Filippi CR, Brickner E, Alvarez LG, Wiat MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.
11. Smart SC, Sawada S, Ryan T, et al. Low dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
12. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26.
13. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
14. Marzulli P, Parodi O, Reisenhofer B, et al. Value of rest thallium-201/ technetium-99m sestambi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166-72.
15. Stahl LD, Aversano TR, Becker LC. Selective enhancement of function of stunned myocardium by increased flow. Circulation 1986;74:843-51.
16. Ito BR, Librathy DH, Engler RL. Effect of transient coronary occlusion on coronary blood flow autoregulation, vasodilator reserve and response to adenosine in the dog. J Am Coll Cardiol 1991;18:858-67.
17. Picano E, Marzullo P, Gigli G, et al. Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy test. Am J Cardiol 1992;70:703-10.
18. Varga A, Ostojic M, Djordjevic-Dikic A, et al. Infra-low dose dipyridamole test: a novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography. Eur Heart J. In press.
19. Gould KL. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Am J Cardiol 1978;41:267-78.
20. Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986;8:848-54.
21. Picano E. Dipyridamole-echocardiography test: the historical background and the physiologic basis. Eur Heart J 1989;10:365-76.
22. Mercier JC, Lando V, Kanmatsuse K, et al. Divergent effects of inotropic stimulation on the ischemic and severely depressed reperfused myocardium. Circulation 1982;66:397-400.
23. Ostojic M, Picano E, Beleslin B, et al. Dipyridamole-dobutamine echocardiography: a novel test for the detection of milder forms of coronary artery disease. J Am Coll Cardiol 1994;23:1115-22.
24. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms: Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
25. Picano E, Lattanzi F, Orlandini A, Marini C, L'Abbate A. Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol 1991;17:666-9.
26. Hoffmann R, Lethen H, Marwick T, et al. Analysis of interinstitutional observer in the interpretation of dobutamine stress echocardiography. J Am Coll Cardiol 1996;27:330-6.
27. Jeremy RW, Sthal L, Gillinov M, Litt M, Aversano TR, Becker LC. Preservation of coronary flow reserve on stunned myocardium. Am J Physiol 1989;25:H1303-10.
28. Gregg DE. Effect of coronary perfusion pressure or coronary flow on oxygen usage of the myocardium. Circ Res 1963;13:497-500.
29. Koretsune Y, Corretti MC, Kusuoka H, Marban E. Mechanism of early ischemic contractile failure. Inexcitability, metabolite accumulation, or vascular collapse? Circ Res 1991;68:255-62.
30. Canty JM, Klocke FJ. Reduced regional myocardial perfusion in the presence of pharmacologic vasodilator reserve. Circulation 1975;71:370-7.
31. Aversano T, Becker LC. Persistence of coronary vasodilator reserve despite functionally significant flow reduction. Am J Physiol 1985;28:H403-11.
32. Parodi O, Sambuceti G, Roghi A, et al. Residual coronary reserve despite decreased resting blood flow in patients with critical coronary lesions. A study by technetium-99m human albumin microsphere myocardial scintigraphy. Circulation 1993;87:330-44.
33. Rovai D, Zanchi M, Lombardi M, et al. Residual myocardial perfusion in reversibly damaged myocardium by dipyridamole contrast echocardiography. Eur Heart J. In press.
34. Marzullo P, Parodi O, Sambuceti G, et al. Residual coronary reserve identifies segmental viability in patients with wall motion abnormalities. J Am Coll Cardiol 1995;26:342-8.
35. Zughaib ME, Abd-Elfattah AS, Jeroudi MO, et al. Augmentation of endogenous adenosine attenuates myocardial "stunning" independently of coronary flow or hemodynamic effects. Circulation 1993;88:2359-69.
36. Ely SW, Mentzer RM, Lasley RD, Lee BK, Berne RM. Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J Thorac Cardiovasc Surg 1985;90:549-56.
37. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 1992;85:893-904.
38. Mills I, Fallon JT, Wrenn D, et al. Adaptive responses of coronary circulation and myocardium to chronic reduction in perfusion pressure and flow. Am J Physiol 1994;266:H447-57.
39. Picano E. Echocardiographic assessment of myocardial viability. In: Picano E: Stress Echocardiography. 2nd ed. Heidelberg, Germany: Springer-Verlag, 1994:128-43.